Australia's largest stock trading and investment forum Australia's #1 stock forum

SIP

Click for more information

1.55%

$1.31 sigma pharmaceuticals limited

Good points jack... Interesting your comment on govt reform....

First 27 Last

Share
Profile

Follow
genericmicrobe

4,188 Posts.

3

22/06/15

14:22

Post #: 15508033
Share

Originally posted by jacktalk ↑

Thin margins are quite ok to me as it makes it extremely difficult to undercut ,it's nice to see skimming of a decent profit from a huge 3 billion$ turnover,I haven't seen any Chemists whinging on govt, static action on reforms, looks to me that the Gov't has seen enough pain has been caused in the the pharmaceutical industry of late with little gain. Argueing that generics /others will supply Chemists themselves has only been done byPfizer,who knows if this has cost them money,do they pay now to have the products delivered by Toll ?,or run around the states driving behind Sigma /Api delivery vans ? that idea does not appear to be catching, more likely the S/price being purposely sold down. But as Warren Buffet says-"there is the share price and the value of the company =U buy when there is an anomoly, now there's a thought..imho

Expand

Good points jack... Interesting your comment on govt reform. luckily I don't see Pfizer model being used by others as not many have the range to make it worthwhile... Sigma has been quite proactive in pushing its generic partnership lately so that could be positive depending on the uptake

SIP Price at posting: 75.5¢ Sentiment: Sell Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 3 more messages in this thread...

First 27 Last

Add SIP (ASX) to my watchlist